Member access

4-Traders Homepage  >  Shares  >  Amex  >  Lannett Company, Inc.    LCI   US5160121019

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. develops, manufactures, markets and distributes generic versions of pharmaceutical products.

The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It manufactures solid oral dosage forms, including tablets and capsules, topical and oral solutions, and is pursuing partnerships and research contracts for the development and production of other dosage forms, including ophthalmic, nasal and injectable products.

The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian682000President, CEO, Director & Head-Investor Relations
Jeffrey Farber532003Chairman
William F. Schreck642003Chief Operating Officer
Martin P. Galvan, CPA612011Chief Financial Officer, Treasurer & VP
Robert Ehlinger562006Chief Information Officer & VP-logistics
William Farber821991Chairman-Emeritus
Kenneth Sinclair, PhD672005Independent Director
David A. Drabik452010Independent Director
Paul Taveira542012Independent Director
James M. Maher602013Independent Director
Shareholders
NameShares%
Jeffrey Farber 5,072,14514.3%
William Farber 3,335,6269.38%
Dimensional Fund Advisors LP 1,193,4123.36%
The Vanguard Group, Inc. 1,059,1052.98%
Invesco PowerShares Capital Management LLC 1,028,7822.89%
SSgA Funds Management, Inc. 921,5342.59%
United Jewish Federation of Metropolitan Detroit 880,4342.48%
BlackRock Fund Advisors 862,2622.42%
Century Capital Management LLC 703,7181.98%
Broadfin Capital LLC 683,5641.92%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
TEVA PHARMACEUTIC..
ALLERGAN, INC.
SHIRE PLC
VALEANT PHARMACEU..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
REGENERON PHARMAC..
Sector Pharmaceuticals
Company contact information
Lannett Co., Inc.
9000 State Road
Philadelphia, PA 19136

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF